Private equity investments in healthcare have dramatically increased in the past few decades. Only recently, however, have pictures emerged about their impact on competition and consumer/patient welfare. Do investors save flailing providers and infuse capital for new technologies? Or do they exploit market failures and regulatory loopholes in pursuit of profits? This panel will discuss and debate.
Moderator: Bevin M.B.Newman
Matthew T. Schock